TISSUE REGENERATION TECHNOLOGIES, LLC

SoftWave TRT is a biomedical device manufacturer specializing in FDA-cleared electrohydraulic shockwave therapy systems for tissue regeneration, pain relief, and healing. Founded in 2004 and headquartered in Kennesaw, Georgia, the company has developed over 30 patents for its proprietary SoftWave® technology, which uses spark-initiated acoustic shockwaves to activate cellular healing responses including stem cell activation and improved blood flow without microtrauma. The flagship OrthoGold device and SoftWave Gold Li-Series platform are designed for orthopedic conditions, musculoskeletal pain, chronic diabetic foot ulcers, acute and chronic wounds, burns, and urological/pelvic health applications. The broad-focused, parallel-dispersion shockwave technology delivers results in 10–15 minute sessions with no downtime, and is deployed across leading medical institutions, university hospitals (Mayo Clinic, UCSF, UPMC), and professional sports organizations (MLB, NFL, NBA, NHL, MLS, NCAA, PGA, UFC). SoftWave TRT serves clinicians in sports medicine, orthopedics, wound care, physical therapy, chiropractic, dermatology, and integrative medicine practices.